Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2025-06-04 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
关于子公司获得政府补助的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (855 characters) from a company about its subsidiary receiving a government subsidy. It details the nature of the subsidy, accounting treatment, and expected impact on profits. There is no financial statement or comprehensive report included, nor is it a transcript, management report, or regulatory certification. The document is an announcement of a specific financial event (government subsidy) related to the company's operations. It does not fit into categories like Annual Report, Interim Report, or Earnings Release, as it lacks comprehensive financial data or results. It is not a report publication announcement since it contains substantive information about the subsidy. The best fitting category is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and disclosures that do not fit other categories.
2025-06-04 Chinese
湘财证券股份有限公司关于西藏易明西雅医药科技股份有限公司详式权益变动报告书之财务顾问核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed financial advisor's verification opinion on a "Detailed Equity Change Report" related to a share transfer transaction involving a listed company. It references specific Chinese securities laws, regulations, and disclosure standards (e.g., "Equity Change Report" format guidelines No. 15 and 16), and extensively discusses the share transfer agreement, shareholding changes, approval procedures, and governance arrangements post-transaction. The document is lengthy (15,000 characters) and contains substantive content including legal and financial due diligence, transaction terms, and governance implications. This is not a mere announcement or certification but a comprehensive report related to a significant equity change transaction. The content aligns with the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including share transfers and equity changes. Therefore, the appropriate classification is CAP with high confidence.
2025-06-03 Chinese
关于控股股东、实际控制人签署《股份转让协议》暨公司控制权拟发生变更的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a significant change in the controlling shareholder and actual controller of the company, involving a share transfer agreement and the potential change of control. It includes specifics about the share transfer, parties involved, payment terms, governance arrangements post-transfer, and risk disclosures. The document does not contain financial statements or quarterly/yearly financial results but focuses on ownership and control changes. This fits the category of Capital/Financing Update (CAP), as it relates to a major transaction affecting the company's capital structure and control. The document length is sufficient and contains substantive details about the transaction, not merely an announcement of a report or a certification. Therefore, the appropriate classification is CAP with high confidence.
2025-06-03 Chinese
关于筹划公司控制权变更事项进展暨公司股票复牌的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a planned change in the company's control and the resumption of trading of its stock. It details the signing of a share transfer agreement, the expected change in controlling shareholder and actual controller, and the stock resumption date. It does not contain financial statements or detailed financial data, nor is it a full report. It is a regulatory announcement about corporate control change and stock trading status. This fits best under Capital/Financing Update (CAP) as it relates to changes in ownership and control, which affect capital structure and shareholder composition. The document length is short (1364 characters), and it is not a report publication announcement or certification. Therefore, the classification is CAP with high confidence.
2025-06-03 Chinese
西藏易明西雅医药科技股份有限公司详式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled '详式权益变动报告书' which translates to 'Detailed Equity Change Report'. It is issued by 西藏易明西雅医药科技股份有限公司 and details a significant equity transaction involving a change in controlling shareholder and actual controller. The document includes sections on the purpose of the equity change, approval procedures, shareholding changes before and after the transaction, the share transfer agreement, payment terms, and related legal and financial disclosures. It references compliance with Chinese securities laws and Shenzhen Stock Exchange regulations regarding share transfers. The content is focused on a detailed report of a significant shareholding change, including the transfer of 23% of shares from one party to another, making the new party the controlling shareholder. This matches the definition of a Major Shareholding Notification (MRQ), which involves notification of changes in significant share ownership levels crossing thresholds. The document is comprehensive and contains substantive details about the shareholding change, not merely an announcement or summary. Therefore, the correct classification is MRQ with high confidence.
2025-06-03 Chinese
西藏易明西雅医药科技股份有限公司简式权益变动报告书（高帆）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding of a significant shareholder (高帆) in 西藏易明西雅医药科技股份有限公司, including the transfer of shares, the agreement terms, and the impact on control of the company. It references relevant Chinese securities laws and regulations, and the Shenzhen Stock Exchange. The content focuses on the disclosure of a change in major shareholding and related agreements, with no financial statements or earnings data. This matches the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document is lengthy and detailed, not a mere announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is MRQ with high confidence.
2025-06-03 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.